Report #2841699

Overview

Sex

Unknown

Age

Age unknown

State

MI

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Becomes immunocompromised following vaccination with Shingrix; This serious case was reported by a physician via call center representative and described the occurrence of immunocompromised in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced immunocompromised (Verbatim: Becomes immunocompromised following vaccination with Shingrix) (serious criteria GSK medically significant). The outcome of the immunocompromised was unknown. It was unknown if the reporter considered the immunocompromised to be related to Shingrix. The company considered the immunocompromised to be unrelated to Shingrix. Additional Information: GSK Receipt Date : 12-MAY-2025 The physician inquired what was the recommendation if somebody did complete a Shingrix vaccine series but then at some point later became immunocompromised because of disease or therapy was there a recommendation to re-vaccinate for booster for immune compromised patients.; Sender's Comments: Immunodeficiency is an unlisted event which is considered unrelated to GSK vaccine Shingrix.